342 related articles for article (PubMed ID: 29135490)
21. Inside Out: HIV, the Gut Microbiome, and the Mucosal Immune System.
Liu J; Williams B; Frank D; Dillon SM; Wilson CC; Landay AL
J Immunol; 2017 Jan; 198(2):605-614. PubMed ID: 28069756
[TBL] [Abstract][Full Text] [Related]
22. The human gut microbiome and its dysfunctions through the meta-omics prism.
Mondot S; Lepage P
Ann N Y Acad Sci; 2016 May; 1372(1):9-19. PubMed ID: 26945826
[TBL] [Abstract][Full Text] [Related]
23. Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.
Pinto-Cardoso S; Klatt NR; Reyes-Terán G
Curr Opin HIV AIDS; 2018 Jan; 13(1):53-60. PubMed ID: 29028667
[TBL] [Abstract][Full Text] [Related]
24. The human microbiome: implications for health and disease, including HIV infection.
Schooley RT
Top Antivir Med; 2018 Sep; 26(3):75-78. PubMed ID: 30384329
[TBL] [Abstract][Full Text] [Related]
25. Application of metagenomics in the human gut microbiome.
Wang WL; Xu SY; Ren ZG; Tao L; Jiang JW; Zheng SS
World J Gastroenterol; 2015 Jan; 21(3):803-14. PubMed ID: 25624713
[TBL] [Abstract][Full Text] [Related]
26. HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets.
Vyboh K; Jenabian MA; Mehraj V; Routy JP
J Immunol Res; 2015; 2015():614127. PubMed ID: 25759844
[TBL] [Abstract][Full Text] [Related]
27. Gut microbial diversity in HIV infection post combined antiretroviral therapy: a key target for prevention of cardiovascular disease.
El-Far M; Tremblay CL
Curr Opin HIV AIDS; 2018 Jan; 13(1):38-44. PubMed ID: 29045253
[TBL] [Abstract][Full Text] [Related]
28. The gut microbiome in human immunodeficiency virus infection.
Zilberman-Schapira G; Zmora N; Itav S; Bashiardes S; Elinav H; Elinav E
BMC Med; 2016 Jun; 14(1):83. PubMed ID: 27256449
[TBL] [Abstract][Full Text] [Related]
29. Potential contribution of gut microbiota and systemic inflammation on HIV vaccine effectiveness and vaccine design.
Routy JP; Mehraj V
AIDS Res Ther; 2017 Sep; 14(1):48. PubMed ID: 28893288
[TBL] [Abstract][Full Text] [Related]
30. Microbial translocation and microbiome dysbiosis in HIV-associated immune activation.
Zevin AS; McKinnon L; Burgener A; Klatt NR
Curr Opin HIV AIDS; 2016 Mar; 11(2):182-90. PubMed ID: 26679414
[TBL] [Abstract][Full Text] [Related]
31. Role of the lung microbiome in HIV pathogenesis.
Shenoy MK; Lynch SV
Curr Opin HIV AIDS; 2018 Jan; 13(1):45-52. PubMed ID: 29035946
[TBL] [Abstract][Full Text] [Related]
32. Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy.
Li SX; Armstrong A; Neff CP; Shaffer M; Lozupone CA; Palmer BE
Clin Pharmacol Ther; 2016 Jun; 99(6):600-11. PubMed ID: 26940481
[TBL] [Abstract][Full Text] [Related]
33. Neonatal Gastrointestinal and Respiratory Microbiome in Cystic Fibrosis: Potential Interactions and Implications for Systemic Health.
Madan JC
Clin Ther; 2016 Apr; 38(4):740-6. PubMed ID: 26973296
[TBL] [Abstract][Full Text] [Related]
34. Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals.
Vázquez-Castellanos JF; Serrano-Villar S; Latorre A; Artacho A; Ferrús ML; Madrid N; Vallejo A; Sainz T; Martínez-Botas J; Ferrando-Martínez S; Vera M; Dronda F; Leal M; Del Romero J; Moreno S; Estrada V; Gosalbes MJ; Moya A
Mucosal Immunol; 2015 Jul; 8(4):760-72. PubMed ID: 25407519
[TBL] [Abstract][Full Text] [Related]
35. The functional consequences of the microbiome in HIV: insights from metabolomic studies.
Serrano-Villar S; Moreno S; Ferrer M
Curr Opin HIV AIDS; 2018 Jan; 13(1):88-94. PubMed ID: 29035945
[TBL] [Abstract][Full Text] [Related]
36. Virus-driven Inflammation Is Associated With the Development of bNAbs in Spontaneous Controllers of HIV.
Dugast AS; Arnold K; Lofano G; Moore S; Hoffner M; Simek M; Poignard P; Seaman M; Suscovich TJ; Pereyra F; Walker BD; Lauffenburger D; Kwon DS; Keele BF; Alter G
Clin Infect Dis; 2017 Apr; 64(8):1098-1104. PubMed ID: 28158448
[TBL] [Abstract][Full Text] [Related]
37. Impact of lincosamides antibiotics on the composition of the rat gut microbiota and the metabolite profile of plasma and feces.
Behr C; Ramírez-Hincapié S; Cameron HJ; Strauss V; Walk T; Herold M; Beekmann K; Rietjens IMCM; van Ravenzwaay B
Toxicol Lett; 2018 Oct; 296():139-151. PubMed ID: 30102961
[TBL] [Abstract][Full Text] [Related]
38. Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection.
Tincati C; Douek DC; Marchetti G
AIDS Res Ther; 2016; 13():19. PubMed ID: 27073405
[TBL] [Abstract][Full Text] [Related]
39. Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral Reservoirs.
Pasquereau S; Kumar A; Herbein G
Viruses; 2017 Mar; 9(4):. PubMed ID: 28358311
[TBL] [Abstract][Full Text] [Related]
40. Gut microbiome and its role in cardiovascular diseases.
Ahmadmehrabi S; Tang WHW
Curr Opin Cardiol; 2017 Nov; 32(6):761-766. PubMed ID: 29023288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
